Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Journal of Biomedicine & Biotechnology|April 14, 2012
Targeting costimulatory molecules to improve antitumor immunityDaria Capece, Daniela Verzella, Mariafausta Fischietti, et al.International Journal of Proteomics|February 13, 2013
Serum biomarkers identification by mass spectrometry in high-mortality tumorsAlessandra Tessitore, Agata Gaggiano, Germana Cicciarelli, et al.Biomed Research International|March 28, 2013
The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophagesDaria Capece, Mariafausta Fischietti, Daniela Verzella, et al.Communications Biology|May 27, 2026
SLFN5 restrains type I interferon responses and promotes glioblastoma via its N-terminal Schlafen core domainRicardo E Perez, Kaitlyn E Kellar, Niyati Hansaria, et al.Current Drug Targets|September 8, 2015
Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach?Daniela Verzella, Mariafausta Fischietti, Daria Capece, et al.International Journal of Genomics|March 12, 2014
MicroRNAs in the DNA Damage/Repair Network and CancerAlessandra Tessitore, Germana Cicciarelli, Filippo Del Vecchio, et al.Anti-Cancer Agents in Medicinal Chemistry|August 25, 2015
Therapeutic Use of MicroRNAs in CancerAlessandra Tessitore, Germana Cicciarelli, Valentina Mastroiaco, et al.Biomed Research International|July 22, 2014
KCTD11 tumor suppressor gene expression is reduced in prostate adenocarcinomaFrancesca Zazzeroni, Daniela Nicosia, Alessandra Tessitore, et al.Arthritis Research & Therapy|September 12, 2015
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblastsPaola Cipriani, Paola Di Benedetto, Piero Ruscitti, et al.Molecular and Cellular Biology|June 6, 2018
Slfn2 Regulates Type I Interferon Responses by Modulating the NF-κB PathwayMariafausta Fischietti, Ahmet D Arslan, Antonella Sassano, et al.Pageof 4